Related Experiment Videos
Typical medication errors in oncology: analysis and prevention strategies
1Pharmacy, Dietrich-Bonhoeffer-Klinikum Neubrandenburg, Germany. MuellerTh@dbk-nb.de
Onkologie
|January 8, 2004
Summary
Oncology pharmacotherapy errors, like overdosage or underdosage, can severely impact treatment success. Strategies such as standardization and specialized software can prevent medication errors in cancer care.
Area of Science:
- Oncology
- Pharmacotherapy
- Patient Safety
Background:
- Cancer pharmacotherapy involves complex treatments with narrow therapeutic indices.
- Medication errors in oncology can lead to severe adverse events or treatment failure.
- Common errors include incorrect administration routes, dosage miscalculations, and device malfunctions.
Purpose of the Study:
- To identify common medication errors in oncology pharmacotherapy.
- To describe the potential consequences of these errors.
- To propose effective prevention strategies for enhancing patient safety.
Main Methods:
- Review of typical medications and procedures prone to errors in chemotherapy.
- Analysis of specific error types, including intrathecal injection, calculation mistakes, and infusion pump issues.
- Identification of preventive measures based on best practices.
Main Results:
- Medication errors in oncology, particularly overdosage and underdosage, significantly affect patient outcomes.
- Specific high-risk scenarios include the administration of platinum compounds and anthracyclines.
- Errors in dose calculation, preparation, and administration device operation are frequently observed.
Conclusions:
- Standardization of protocols and clear separation of administration routes (intrathecal vs. intravenous) are crucial.
- Specialized software for chemotherapy planning and calculation can minimize errors.
- Implementing non-punitive reporting systems for errors and near-errors is vital for continuous improvement in cancer patient safety.